AstraZeneca's Imfinzi Perioperative Regimen Shows Improved Survival Outcomes In Bladder Cancer Patients
AstraZeneca's Imfinzi perioperative regimen improved survival outcomes in muscle-invasive bladder cancer, with FDA Priority ...
Pliant Therapeutics: Strange Volatility
Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.
MM&M5d
Rx Rundown: Sanofi, Bristol Myers Squibb, Omega Therapeutics and more
Amazon Music and WPP unveiled Louder Than Cancer, an effort uniting top global artists to harness the power of music in recognition of World Cancer Day with creative leadership from WPP’s Grey Health, ...
pharmaphorum4d
A history of AstraZeneca
In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune ... right patient, right safety and right commercial. ‘Right patient’, for example, is about finding the patient ...
redstateobserver5d
COVID Vaccines May Trigger Autoimmune Disease Risks
COVID Vaccines Linked to Autoimmune Disease** In a groundbreaking development, recent research has unveiled that COVID-19 vaccines may act as a trigger for ...
pharmaphorum2d
New malaria vaccine shows high efficacy, yields high hopes
A malaria vaccine developed by members of the University of Oxford team behind the AstraZeneca COVID-19 jab ... phase 3 trial continues to support its safety and efficacy. Meanwhile, the phase ...
The Canadian Press on MSN1d
Today-History-Feb26
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
Hosted on MSN6d
Scientists sound alarm over unexpected vaccine safety issue: 'Especially problematic'
The problem extends beyond the vaccines. Scientists sound alarm over unexpected vaccine safety issue: 'Especially problematic ...
Taiwan News2d
North America Preventive Vaccines Market Guiding Principles Key Strategies for Effective Focus Group Facilitation
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several ...
Taiwan News2d
Asia Pacific Preventive Vaccines Market Elevating Engagement Making Focus Groups a Catalyst for Insights
Request To Download Free Sample of This Strategic Report @ Highlighted with 59 tables and 54 figures, this 141-page report ?Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, ...
PharmiWeb5d
Pharmaceutical Market: Shaping the Future of Healthcare and Medicine
Pharmaceutical Market Size and Growth 2025 to 2034The global pharmaceutical market size was valued at USD 1,607.07 billion in ...
Respiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider
Therapeutics Market Growth is Driven by Increased Awareness of RSV’s Health Risks and The Development of Advanced Treatment Options.Pune, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Respiratory Syncytial Virus ...